Jolanda Howe Mirum Pharmaceuticals, Inc. (MIRM) insider trading activity

MIRM Quotes by TradingView

Jolanda Howe is SVP, GLOBAL CONTROLLER of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 2,426 shares of MIRM, which is worth approximately $111,790. The most recent transaction as insider was on Mar 18, 2025, when has been sold 2,415 shares (Common Stock) at a price of $44.45 per share, resulting in proceeds of $107,346. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.43K
0% 3M change
37.92% 12M change
Total Value Held $111,790

Jolanda Howe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2025
SELL
Open market or private sale
$107,346 $44.45 p/Share
2,415 Reduced 49.89%
2,426 Common Stock
Mar 17 2025
SELL
Open market or private sale
$2,558,282 $44.41 p/Share
57,606 Reduced 92.25%
4,841 Common Stock
Mar 17 2025
BUY
Exercise of conversion of derivative security
$155,526 $2.94 p/Share
52,900 Added 47.04%
59,547 Common Stock
Mar 15 2025
BUY
Exercise of conversion of derivative security
-
5,315 Added 35.76%
9,547 Common Stock
Feb 03 2025
SELL
Open market or private sale
$51,306 $48.22 p/Share
1,064 Reduced 20.09%
4,232 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
1,772 Added 25.07%
5,296 Common Stock
Jan 24 2025
SELL
Open market or private sale
$43,223 $47.92 p/Share
902 Reduced 20.38%
3,524 Common Stock
Jan 23 2025
BUY
Exercise of conversion of derivative security
-
1,500 Added 25.31%
4,426 Common Stock
Jan 07 2025
SELL
Open market or private sale
$32,115 $42.82 p/Share
750 Reduced 20.4%
2,926 Common Stock
Jan 06 2025
BUY
Exercise of conversion of derivative security
-
1,250 Added 25.38%
3,676 Common Stock
Nov 14 2024
SELL
Open market or private sale
$117,750 $47.1 p/Share
2,500 Reduced 50.75%
2,426 Common Stock
Nov 14 2024
BUY
Exercise of conversion of derivative security
$7,350 $2.94 p/Share
2,500 Added 33.67%
4,926 Common Stock
Jul 02 2024
SELL
Open market or private sale
$12,750 $34.0 p/Share
375 Reduced 13.39%
2,426 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
-
1,042 Added 27.11%
2,801 Common Stock
Feb 02 2024
SELL
Open market or private sale
$19,249 $26.19 p/Share
735 Reduced 29.47%
1,759 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
-
1,772 Added 41.54%
2,494 Common Stock
Jan 08 2024
SELL
Open market or private sale
$14,805 $28.04 p/Share
528 Reduced 42.24%
722 Common Stock
Jan 06 2024
BUY
Exercise of conversion of derivative security
-
1,250 Added 50.0%
1,250 Common Stock
Dec 05 2023
SELL
Open market or private sale
$81,000 $32.4 p/Share
2,500 Reduced 100.0%
0 Common Stock
Dec 05 2023
BUY
Exercise of conversion of derivative security
$7,350 $2.94 p/Share
2,500 Added 50.0%
2,500 Common Stock
Aug 25 2023
SELL
Open market or private sale
$90,729 $26.23 p/Share
3,459 Reduced 100.0%
0 Common Stock
Jul 03 2023
SELL
Open market or private sale
$23,469 $25.65 p/Share
915 Reduced 20.92%
3,459 Common Stock
Jul 01 2023
BUY
Exercise of conversion of derivative security
-
1,042 Added 19.24%
4,374 Common Stock
Jun 30 2023
BUY
Exercise of conversion of derivative security
-
1,563 Added 31.93%
3,332 Common Stock
JH

Jolanda Howe

SVP, GLOBAL CONTROLLER
Foster City, CA

Track Institutional and Insider Activities on MIRM

Follow Mirum Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

News

Receive news related to Mirum Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MIRM